Call For Abstract


The scientific committee is delighted to receive your abstract for the 14th SEHA INTERNATIONAL PEDIATRIC CONFERENCE that will take place on 16th-18th January, 2020 at Rosewood Hotel, Abu Dhabi, UAE.

Abstracts will be peer reviewed for quality of research, educational or scientific content, logical presentation and impact on nursing, midwifery and allied health. Participants are encouraged to show real life examples of what works and practical take-away tools/solutions.


Submissions are welcome in all topics related to Pediatric Medicine but not limited to:

  • General Pediatrics
  • Pediatric Rheumatology 
  • Endocrinology
  • Genetics & Metabolic
  • Gastroenterology
  • Pulmonology
  • Paediatric Hematology/Oncology
  • Infection
  • PICU
  • Cardiology
  • Neurology
  • Allergy
  • Immunology
  • Nephrology
  • Emergency
  • Quality
  • Patient safety


For Accepted Abstracts:

·         For abstracts with multiple authors: WILL NEED to agree on one person that will be solely presenting the abstract in the conference

·         The Main author/ presenting author will:

o   get complimentary registration on the day that he/she is scheduled to present in the conference

o   will receive a certificate of attendance and appreciation for his/her presentation/participation in the conference

·         Presenter must not use the session as a marketing opportunity for products/equipment

·         Travel/accommodation expenses WILL NOT be provided


·         A maximum of 2 abstracts can be submitted.

·         Abstracts must include sufficient information for reviewers to judge the nature and significance of the topic, the adequacy of the investigative strategy, the nature of the results, and the conclusions.

·         The abstract should summarize the substantive results of the work and not merely list topics to be discussed.

·         Abstracts must contain original scientific data collected by the author(s). All reports must be based on work that has already been completed. No studies "in progress" will be accepted. 

·         Presentation format: Accepted abstracts are scheduled as either poster or oral presentation based on relevance, best practices, case studies and completeness of the required information submitted. Authors may submit abstracts for poster presentation only but the scientific committee will have the final decision on accepting submissions and assigning the category or presentation format.

·         Language and length: Please follow the maximum word count as indicated in each section. Do not include names of specific individuals, institutions, pharmaceutical companies, or specific manufacturers in the body of the abstract.

·         Abstract body:  At this point, NO figures or tables are to be included yet in the abstract.


Notification of Acceptance:

                    27th November 2019 | Deadline for submission of abstracts

                    12th December 2019 | Notification for accepted abstracts



Abstract submission will be acknowledged via email. If no acknowledgement received within a week of submission or if you have any additional queries please email:


  • Abstracts must be submitted online (download link pending)
  • Please use Google Chrome or Firefox or Explorer (8 or up) 
  • Alternatively, download Abstract Form from the website
For clarifications, please contact: ;
+971 24919888
Attach Abstract Presentation
Allowed file formats : Pdf .doc . Docx only
* Fields are mandatory.






Media Partner